David W. Crabb spends much of his time researching Internal medicine, Endocrinology, Biochemistry, Ethanol metabolism and ALDH2. His Endocrinology study frequently links to adjacent areas such as Fatty acid synthesis. In most of his Biochemistry studies, his work intersects topics such as Molecular biology.
His Ethanol metabolism research integrates issues from Acetaldehyde and Alcohol dehydrogenase. As a member of one scientific family, David W. Crabb mostly works in the field of Alcohol dehydrogenase, focusing on Genetics and, on occasion, Biotechnology. His Aldehyde dehydrogenase study which covers Allele that intersects with Genotype.
David W. Crabb mostly deals with Internal medicine, Biochemistry, Endocrinology, Molecular biology and Alcohol dehydrogenase. The Internal medicine study combines topics in areas such as Alcohol and Gastroenterology. His work on Biochemistry deals in particular with Enzyme, Aldehyde dehydrogenase, Acetaldehyde, Complementary DNA and ALDH2.
His Endocrinology study integrates concerns from other disciplines, such as Enzyme assay and Protein kinase A. The study incorporates disciplines such as Gene expression, Transcription factor, Peptide sequence, Reporter gene and Gene in addition to Molecular biology. David W. Crabb has included themes like Ethanol metabolism, Metabolism and Kidney in his Alcohol dehydrogenase study.
David W. Crabb mainly investigates Alcoholic hepatitis, Internal medicine, Alcoholic liver disease, Liver disease and Alcohol. The concepts of his Internal medicine study are interwoven with issues in Gastroenterology, Endocrinology and MEDLINE. He has researched Alcoholic liver disease in several fields, including Alcohol dependence, Cohort, Pathology, Substance abuse and Single-nucleotide polymorphism.
His Alcohol dependence study incorporates themes from ALDH2, Gene polymorphism, Aldehyde dehydrogenase, Genotype and Alcohol dehydrogenase. His study looks at the intersection of Liver disease and topics like Gene with Microbiome, Bacteria and Monocyte. His Alcohol course of study focuses on Liver transplantation and Alcoholism therapy, Fatty liver and Medical nutrition therapy.
His primary areas of study are Alcoholic hepatitis, Liver disease, Internal medicine, Alcohol and MEDLINE. His Alcoholic hepatitis study combines topics in areas such as Alcohol abuse and Pathology. His study in Liver disease is interdisciplinary in nature, drawing from both Single-nucleotide polymorphism, Gene and Immunology, Monocyte.
His work on Metagenomics as part of his general Gene study is frequently connected to Fusobacteria, thereby bridging the divide between different branches of science. Body mass index, Odds ratio and Model for End-Stage Liver Disease are the subjects of his Internal medicine studies. David W. Crabb focuses mostly in the field of Alcohol, narrowing it down to matters related to Liver transplantation and, in some cases, Alcohol use disorder, Alcoholism therapy, Fatty liver and Medical nutrition therapy.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Alcohol and aldehyde dehydrogenase genotypes and alcoholism in Chinese men.
Holly Read Thomasson;Howard J. Edenberg;David W. Crabb;Xiao Ling Mai.
American Journal of Human Genetics (1991)
Genotypes for aldehyde dehydrogenase deficiency and alcohol sensitivity. The inactive ALDH2(2) allele is dominant.
D W Crabb;H J Edenberg;W F Bosron;T K Li.
Journal of Clinical Investigation (1989)
Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element-binding protein (SREBP).
Min You;Monika Fischer;Mark A. Deeg;David W. Crabb.
Journal of Biological Chemistry (2002)
Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro.
Andrea Galli;David W. Crabb;Elisabetta Ceni;Renata Salzano.
Overview of the role of alcohol dehydrogenase and aldehyde dehydrogenase and their variants in the genesis of alcohol-related pathology
David W. Crabb;Michinaga Matsumoto;David Chang;Min You.
Proceedings of the Nutrition Society (2004)
Systemic Levels of Lipid Peroxidation and Its Metabolic and Dietary Correlates in Patients with Nonalcoholic Steatohepatitis
Naga Chalasani;Mark A Deeg;David W Crabb.
The American Journal of Gastroenterology (2004)
The role of AMP-activated protein kinase in the action of ethanol in the liver.
Min You;Michinaga Matsumoto;Christine M. Pacold;Won Kyoo Cho.
Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis
Naga Chalasani;J. Christopher Gorski;Maleeha S. Asghar;Ali Asghar.
Alcohol and Medication Interactions
Ron Weathermon;David W. Crabb.
Alcohol Research & Health (1999)
Standard Definitions and Common Data Elements for Clinical Trials in Patients With Alcoholic Hepatitis: Recommendation From the NIAAA Alcoholic Hepatitis Consortia
David W. Crabb;Ramon Bataller;Naga P. Chalasani;Patrick S. Kamath.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: